EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 43, No. 7, 427-435, July 2011 Discovery of the serum biomarker proteins in severe preeclampsia by proteomic analysis Jisook Park1*, Dong Hyun Cha2*, Soo Jae Lee1, further validate the candidate proteins with a quantita- Young Nam Kim3, Young Hwan Kim4 tive mass spectrometric method, selective reaction and Kwang Pyo Kim1,5 monitoring (SRM) and enzyme linked immune assay (ELISA) of serum samples collected from pregnant 1Department of Molecular Biotechnology women with severe PE (n = 8) or normal pregnant wom- Institute of Biomedical Science and Technology en (n = 5) was conducted. α2- HS-glycoprotein (AHSG), Konkuk University retinol binding protein 4 (RBP4) and α-1-micro- Seoul 143-701, Korea globulin/bikunin (AMBP) and Insulin like growth factor 2Department of Obstetrics and Gynecology binding protein, acid labile subunit (IGFBP-ALS) were Kangnam CHA Hospital confirmed to be differentially expressed in PE using CHA University SRM (P < 0.05). Among these proteins, AHSG was Seoul 135-080, Korea verified by ELISA and showed a statistically significant 3Department of Obstetrics and Gynecology increase in PE samples when compared to controls. Inje University Pusan Paik Hospital Keywords: α2HS-glycoprotein; biomarkers; pre-eclamp- Busan 614-735, Korea sia; spectrometry, mass, electrospray ionization; pro- 4Division of Mass Spectrometry Research teomics; serum Korea Basic Science Institute Ochang 363-883, Korea 5Corresponding author: Tel, 82-2-458-7682; Introduction Fax, 82-2-452-5558; E-mail,
[email protected] *These authors contributed equally to this work. Preeclampsia (PE) is a disorder defined by DOI 10.3858/emm.2011.43.7.047 new-onset hypertension and proteinuria after 20 weeks of gestation that can present as late as 4-6 Accepted 31 May 2011 weeks postpartum.